Data / Drug companies / American Health Packaging
American Health Packaging: 153 products in the FDA NDC directory, labeler code 68084
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
American Health Packaging (labeler code 68084) lists 153 products in the FDA National Drug Code Directory, covering 81 finished drugs by generic name. By type: 150 prescription drugs, 3 over the counter drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on September 21, 2023.
The request: Watch American Health Packaging (FDA labeler code 68084): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 68084
- Products in commercial distribution
- 153
- Packages
- 167
- Finished drugs by generic name
- 81
- Prescription products
- 150
- Over the counter products
- 3
- Controlled substance products
- Schedule II 10, Schedule IV 3
- Started marketing in the last 12 months
- 0
- Products with a marketing end date set
- 5
- Earliest marketing start
- March 15, 2005
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 148 | 96.7% |
| New drug applications (NDA) | 3 | 2% |
| Authorized generics (NDA) | 1 | 0.7% |
| Over the counter monograph drugs | 1 | 0.7% |
Products by type
| Type | Products | Share |
|---|---|---|
| Prescription drugs | 150 | 98% |
| Over the counter drugs | 3 | 2% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, film coated | 53 | 34.6% |
| Tablet | 52 | 34% |
| Capsule | 20 | 13.1% |
| Tablet, film coated, extended release | 9 | 5.9% |
| Tablet, extended release | 6 | 3.9% |
| Capsule, extended release | 4 | 2.6% |
| Tablet, delayed release | 4 | 2.6% |
| Capsule, gelatin coated | 2 | 1.3% |
| Capsule, coated pellets | 1 | 0.7% |
| Tablet, coated | 1 | 0.7% |
| Tablet, chewable | 1 | 0.7% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Ondansetron Hydrochloride | 68084-221 | Tablet, film coated | Generic drugs (ANDA) | September 21, 2023 |
| Ondansetron Hydrochloride | 68084-220 | Tablet, film coated | Generic drugs (ANDA) | September 21, 2023 |
| Carbamazepine | 68084-444 | Tablet | Generic drugs (ANDA) | June 2, 2023 |
| Benzonatate | 68084-214 | Capsule | Generic drugs (ANDA) | May 26, 2021 |
| Oxycodone hydrochloride | 68084-975 | Tablet | Generic drugs (ANDA) | February 25, 2020 |
| Oxycodone hydrochloride | 68084-983 | Tablet | Generic drugs (ANDA) | February 10, 2020 |
| Topiramate | 68084-343 | Tablet, film coated | Generic drugs (ANDA) | November 8, 2019 |
| Oxycodone hydrochloride | 68084-968 | Tablet | Generic drugs (ANDA) | February 8, 2019 |
| Prazosin Hydrochloride | 68084-996 | Capsule | Generic drugs (ANDA) | July 12, 2018 |
| Prazosin Hydrochloride | 68084-997 | Capsule | Generic drugs (ANDA) | May 11, 2018 |
| Triamterene and Hydrochlorothiazide | 68084-750 | Tablet | Generic drugs (ANDA) | March 21, 2016 |
| Mucinex | 68084-572 | Tablet, extended release | New drug applications (NDA) | February 19, 2016 |
| Clomipramine hydrochloride | 68084-790 | Capsule | Generic drugs (ANDA) | February 1, 2016 |
| Divalproex Sodium | 68084-782 | Tablet, delayed release | Generic drugs (ANDA) | January 26, 2016 |
| Tizanidine | 68084-775 | Tablet | Generic drugs (ANDA) | January 25, 2016 |
| Cyclobenzaprine Hydrochloride | 68084-753 | Tablet, film coated | Generic drugs (ANDA) | January 4, 2016 |
| Antacid Peppermint Flavour Regular Strength | 68084-988 | Tablet, chewable | Over the counter monograph drugs | November 16, 2015 |
| Sirolimus | 68084-915 | Tablet | Generic drugs (ANDA) | November 5, 2015 |
| Cyclosporine | 68084-921 | Capsule, gelatin coated | Generic drugs (ANDA) | November 3, 2015 |
| Propylthiouracil | 68084-964 | Tablet | New drug applications (NDA) | October 8, 2015 |
| Cyclosporine | 68084-879 | Capsule, gelatin coated | Generic drugs (ANDA) | September 30, 2015 |
| Venlafaxine | 68084-896 | Tablet | Generic drugs (ANDA) | September 29, 2015 |
| Pilocarpine hydrochloride | 68084-928 | Tablet, film coated | Authorized generics (NDA) | September 25, 2015 |
| Albuterol Sulfate | 68084-949 | Tablet | Generic drugs (ANDA) | September 22, 2015 |
| Venlafaxine | 68084-844 | Tablet | Generic drugs (ANDA) | May 13, 2015 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.